Persistence, adherence, healthcare resource utilization and costs for ocrelizumab in the real-world of the Campania Region of Italy

AIMS: We aim to provide real-world evidence on the use of ocrelizumab for treating multiple sclerosis (MS), with specific regard to prescription pattern, adherence, persistence, healthcare resource utilization and related costs, also in relation to other disease-modifying treatments (DMTs). METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Moccia, Marcello, Affinito, Giuseppina, Berera, Giulia, Marrazzo, Giuseppina, Piscitelli, Raffaele, Carotenuto, Antonio, Petracca, Maria, Lanzillo, Roberta, Triassi, Maria, Brescia Morra, Vincenzo, Palladino, Raffaele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618479/
https://www.ncbi.nlm.nih.gov/pubmed/35953597
http://dx.doi.org/10.1007/s00415-022-11320-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618479/
https://www.ncbi.nlm.nih.gov/pubmed/35953597
http://dx.doi.org/10.1007/s00415-022-11320-7

Ejemplares similares